Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Piazza

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of the Medical Library Association : JMLA|October 21, 2024
Standing up for representation in undergraduate medical education curricula through medical student, librarian, and faculty collaboration: a case reportEllen M Hong, Rami Atoot, Megan E Decker, et al.
Tumori|January 1, 1996
Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancerL Frontini, P Candido, M T Cattaneo, et al.
Journal of Chemotherapy (Florence, Italy)|February 11, 2005
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in OncologyM Cantore, G Fiorentini, G Luppi, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Anticancer Research|August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II studyS Barni, M Visini, E Piazza, et al.
British Journal of Cancer|August 23, 2000
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin InvestigatorsC Gridelli, L Frontini, F Perrone, et al.
Environmental Science and Pollution Research International|April 15, 2015
Effect of linear alkylbenzene mixtures and sanitary sewage in biochemical and molecular responses in pacific oyster Crassostrea gigasFabrício Flores-Nunes, Jacó J Mattos, Flávia L Zacchi, et al.
Chemosphere|September 26, 2022
Life after death? Exploring biochemical and molecular changes following organismal death in green turtles, Chelonia mydas (Linnaeus, 1758)B P H Righetti, D Lima, V H V Dias, et al.
Haematologica|March 1, 1996
Familial AL-amyloidosis in three Italian siblingsA Miliani, F Bergesio, M Salvadori, et al.
Oncology|October 2, 2004
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-upS Barni, E Piazza, L Frontini, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of the Medical Library Association : JMLA|October 21, 2024
Standing up for representation in undergraduate medical education curricula through medical student, librarian, and faculty collaboration: a case reportEllen M Hong, Rami Atoot, Megan E Decker, et al.
Tumori|January 1, 1996
Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancerL Frontini, P Candido, M T Cattaneo, et al.
Journal of Chemotherapy (Florence, Italy)|February 11, 2005
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in OncologyM Cantore, G Fiorentini, G Luppi, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Anticancer Research|August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II studyS Barni, M Visini, E Piazza, et al.
British Journal of Cancer|August 23, 2000
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin InvestigatorsC Gridelli, L Frontini, F Perrone, et al.
Environmental Science and Pollution Research International|April 15, 2015
Effect of linear alkylbenzene mixtures and sanitary sewage in biochemical and molecular responses in pacific oyster Crassostrea gigasFabrício Flores-Nunes, Jacó J Mattos, Flávia L Zacchi, et al.
Chemosphere|September 26, 2022
Life after death? Exploring biochemical and molecular changes following organismal death in green turtles, Chelonia mydas (Linnaeus, 1758)B P H Righetti, D Lima, V H V Dias, et al.
Haematologica|March 1, 1996
Familial AL-amyloidosis in three Italian siblingsA Miliani, F Bergesio, M Salvadori, et al.
Oncology|October 2, 2004
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-upS Barni, E Piazza, L Frontini, et al.
Pageof 6